Literature DB >> 11934831

Phosphorylation of troponin I controls cardiac twitch dynamics: evidence from phosphorylation site mutants expressed on a troponin I-null background in mice.

YeQing Pi1, Kara R Kemnitz, Dahua Zhang, Evangelia G Kranias, Jeffery W Walker.   

Abstract

The cardiac myofilament protein troponin I (cTnI) is phosphorylated by protein kinase C (PKC), a family of serine/threonine kinases activated within heart muscle by a variety of agonists. cTnI is also a substrate for cAMP-dependent protein kinase (PKA) activated during beta-adrenergic signaling. To investigate the role of cTnI phosphorylation in contractile regulation by these pathways, we generated transgenic mice harboring a mutated cTnI protein lacking phosphorylation sites for PKC (serine(43/45) and threonine(144) mutated to alanine) and for PKA (serine(23/24) mutated to alanine). Transgenic mice were interbred with cTnI-knockout mice to ensure the absence of endogenous phosphorylatable cTnI. Here, we report that regulation of myocyte twitch kinetics by beta-stimulation and by endothelin-1 was altered in myocytes containing mutant cTnI. In wild-type myocytes, the beta-agonist isoproterenol decreased twitch duration and relaxation time constant (tau) by 37% to 44%. These lusitropic effects of isoproterenol were reduced by about half in nonphosphorylatable cTnI mutant myocytes and were absent in cTnI mutants also lacking phospholamban (generated by crossing cTnI mutants with phospholamban-knockout mice). These observations are consistent with important roles for both cTnI and phospholamban phosphorylation in accelerating relaxation after beta-adrenergic stimulation. In contrast, endothelin-1 increased twitch duration by 32% and increased tau by 58%. These endothelin-1 effects were substantially blunted in nonphosphorylatable cTnI myocytes, indicating that PKC phosphorylation of cTnI slows cardiac relaxation and increases twitch duration. We propose that beta-agonists and endothelin-1 regulate cardiac twitch dynamics in opposite directions in part through phosphorylation of the myofilament protein cTnI on distinct sites.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11934831     DOI: 10.1161/01.res.0000014080.82861.5f

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  52 in total

1.  Myofilament-based relaxant effect of isoprenaline revealed during work-loop contractions in rat cardiac trabeculae.

Authors:  Joanne Layland; Jonathan C Kentish
Journal:  J Physiol       Date:  2002-10-01       Impact factor: 5.182

Review 2.  The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation.

Authors:  R John Solaro; Paul Rosevear; Tomoyoshi Kobayashi
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

3.  Augmented phosphorylation of cardiac troponin I in hypertensive heart failure.

Authors:  Xintong Dong; C Amelia Sumandea; Yi-Chen Chen; Mary L Garcia-Cazarin; Jiang Zhang; C William Balke; Marius P Sumandea; Ying Ge
Journal:  J Biol Chem       Date:  2011-11-03       Impact factor: 5.157

4.  Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.

Authors:  Marco L Alves; Fernando A L Dias; Robert D Gaffin; Jillian N Simon; Eric M Montminy; Brandon J Biesiadecki; Aaron C Hinken; Chad M Warren; Megan S Utter; Robert T Davis; Sadayappan Sakthivel; Jeffrey Robbins; David F Wieczorek; R John Solaro; Beata M Wolska
Journal:  Circ Cardiovasc Genet       Date:  2014-02-28

5.  Phosphorylation of protein kinase C sites Ser42/44 decreases Ca(2+)-sensitivity and blunts enhanced length-dependent activation in response to protein kinase A in human cardiomyocytes.

Authors:  Paul J M Wijnker; Vasco Sequeira; E Rosalie Witjas-Paalberends; D Brian Foster; Cristobal G dos Remedios; Anne M Murphy; Ger J M Stienen; Jolanda van der Velden
Journal:  Arch Biochem Biophys       Date:  2014-05-09       Impact factor: 4.013

6.  Independent modulation of contractile performance by cardiac troponin I Ser43 and Ser45 in the dynamic sarcomere.

Authors:  Sarah E Lang; Jennifer Schwank; Tamara K Stevenson; Mark A Jensen; Margaret V Westfall
Journal:  J Mol Cell Cardiol       Date:  2014-12-03       Impact factor: 5.000

7.  Distinct sarcomeric substrates are responsible for protein kinase D-mediated regulation of cardiac myofilament Ca2+ sensitivity and cross-bridge cycling.

Authors:  Sonya C Bardswell; Friederike Cuello; Alexandra J Rowland; Sakthivel Sadayappan; Jeffrey Robbins; Mathias Gautel; Jeffery W Walker; Jonathan C Kentish; Metin Avkiran
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

8.  Calcium sensitivity, force frequency relationship and cardiac troponin I: critical role of PKA and PKC phosphorylation sites.

Authors:  Genaro A Ramirez-Correa; Sonia Cortassa; Brian Stanley; Wei Dong Gao; Anne M Murphy
Journal:  J Mol Cell Cardiol       Date:  2010-01-18       Impact factor: 5.000

Review 9.  What we know and do not know about sex and cardiac disease.

Authors:  John P Konhilas
Journal:  J Biomed Biotechnol       Date:  2010-04-22

10.  Myofilament incorporation and contractile function after gene transfer of cardiac troponin I Ser43/45Ala.

Authors:  Sarah E Lang; Dustin A Robinson; Helen C Wu; Todd J Herron; Philip A Wahr; Margaret V Westfall
Journal:  Arch Biochem Biophys       Date:  2013-01-11       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.